The prognostic value of CEA, beta HCG, AFP, CA125, CA19-9 and C-erb B-2, beta HCG immunohistochemistry in advanced colorectal cancer.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Annals of Oncology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 8573538
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer.

  1993cited by this paper
• Elevated CA19‐9 as the most significant prognostic factor in advanced colorectal carcinoma

  1992cited by this paper
• c-erbB-2/neu in colorectal carcinoma: a potential prognostic value?

  1992cited by this paper
• HER2 (c-erbB-2) oncoprotein expression in colorectal adenocarcinoma: an immunohistological study using three different antibodies.

  1992cited by this paper
• Use of serum tumor markers in the differential diagnosis between ovarian and colorectal adenocarcinomas.

  1992cited by this paper
• Prognostic value of CA 19.9 levels in colorectal cancer.

  1992cited by this paper
• A phase ii study of the combination of etoposide and cisplatin in the therapy of advanced gastric cancer

  1990cited by this paper
• Carcinoembryonic antigen as a selective enhancer of colorectal cancer metastasis.

  1990cited by this paper
• Expression of the p185 encoded by her2 oncogene in normal and transformed human tissues

  1990cited by this paper
• c‐erbB‐2 oncoprotein expression in primary human tumors

  1990cited by this paper
• Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer.

  1990cited by this paper
• Expression of the c-erbB-2 gene product (p185) at different stages of neoplastic progression in the colon.

  1989cited by this paper
• Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer.

  1989cited by this paper
• Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1.

  1989cited by this paper
• Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

  1989cited by this paper
• Prognostic variables in patients with hepatic metastases from colorectal cancer. Importance of medical assessment of liver involvement

  1989cited by this paper
• Human chorionic gonadotropin in colorectal cancer and its relationship to prognosis.

  1989cited by this paper
• Amplification of c‐myc and c‐erbB‐2 proto‐oncogenes in human solid tumors: Frequency and clinical significance

  1989cited by this paper
• Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule.

  1989cited by this paper
• Determinants of survival in patients with unresectable colorectal liver metastases

  1989cited by this paper
• Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading.

  1988cited by this paper
• Carcinoembryonic antigen and carbohydrate antigen 19‐9 levels of peripheral and draining venous blood in colorectal cancer patients correlation with histopathologic and immunohistochemical variables

  1988cited by this paper
• Growth potential of human colorectal carcinomas in nude mice: association with the preoperative serum concentration of carcinoembryonic antigen in patients.

  1988cited by this paper
• Comparative effectiveness of the tumour diagnostics, CA 19-9, CA 125 and carcinoembryonic antigen in patients with diseases of the digestive system.

  1987cited by this paper
• Use of serum tumor markers in cancer diagnosis and management.

  1987cited by this paper
• Human chorionic gonadotropin in colorectal carcinoma an immunohistochemical study

  1987cited by this paper
• Human chorionic gonadotrophin expression in colorectal adenocarcinoma

  1986cited by this paper
• Clinical Significance of Serum CA125 Values in Patients with Cancers of the Digestive System

  1986cited by this paper
• Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo.

  1986cited by this paper
• Carcinoembryonic antigen.

  1986cited by this paper
• Measurement of a monoclonal‐antibody‐defined antigen (CA 19‐9) in the sera of patients with malignant and nonmalignant diseases comparison with carcinoembryonic antigen

  1985cited by this paper
• Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker.

  1984cited by this paper
• Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases.

  1984cited by this paper
• A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.

  1983cited by this paper
• The serum levels of human alpha-fetoprotein, AFP, choriogonadotropin, hCG, placental lactogen, hPL, and pregnancy-specific beta 1-glycoprotein, SP1, are of no clinical significance in colorectal carcinoma.

  1981cited by this paper
• Correlation of Plasma CEA and CEA tissue staining in poorly differentiated colorectal cancer.

  1981cited by this paper
• Clinical value of carcinoembryonic antigen: diagnosis, prognosis, and follow-up of patients with cancer.

  1979cited by this paper
• An immunohistochemical study of the significance of HCG secretion by large bowel adenocarcinomata.

  1979cited by this paper
• Serial plasma carcinoembryonic antigen measurements in the management of metastatic colorectal carcinoma.

  1978cited by this paper
• Carcinoembryonic antigen (CEA) in clinical medicine. Historical perspectives, pitfalls and projections

  1978cited by this paper
• Biological markers in breast carcinoma: II. Clinical correlations with human chorionic gonadotrophin

  1977cited by this paper
• Serum alphafetoprotein in hepatocellular carcinoma

  1977cited by this paper
• Human chorionic gonadotrophins (hCG) in nontrophoblastic neoplasms. Assessment of abnormalities of hCG and CEA in bronchogenic and digestive neoplasms

  1976cited by this paper
• Placental proteins and their subunits as tumor markers.

  1975cited by this paper
• Serum alpha-fetoprotein in patients with neoplasms of the gastrointestinal tract.

  1975cited by this paper
• alpha-fetoprotein in noneoplastic hepatic disorders.

  1975cited by this paper
• The clinical application of a specific radioimmunoassay for human chorionic gondotropin in trophoblastic and nontrophoblastic tumors.

  1974cited by this paper
• Ectopic production of human chorionic gonadotrophin by neoplasms.

  1973cited by this paper

• Circulating extrachromosomal circular DNA as a prognostic biomarker for colorectal cancer.

  2026cites this paper
• Raised Serum Tumour Markers Predict Incomplete Cytoreduction, Disease-Free and Overall Survival in Patients with Colorectal Peritoneal Metastases Treated by Cytoreductive Surgery and HIPEC.

  2026cites this paper
• Long-term SiNPs exposure induced genetic instability and malignant transformation via SQSTM1/p62-mediated autophagy dysfunction in lungs

  2025cites this paper
• An ABCC1-based risk model is effective in the diagnosis of synchronous peritoneal metastasis in advanced colorectal cancer

  2025cites this paper
• Serum β‑hCG as a prognostic marker for colorectal adenocarcinoma in women of reproductive age: A case report and literature review

  2024cites this paper
• Elevated CA19-9 within the normal range suggests poorer prognosis in stage II CRC: A retrospective analysis of a large sample in a single center.

  2024cites this paper
• Carcinoembryonic antigen kinetics predict response to first-line treatment in metastatic colorectal cancer: Analysis from PRODIGE 9 trial.

  2023cites this paper
• Discovery of extracellular vesicle-delivered miR-185-5p in the plasma of patients as an indicator for advanced adenoma and colorectal cancer

  2023influential citation
• Prognostic value of normal levels of preoperative tumor markers in colorectal cancer

  2023cites this paper
• Preoperative serum CA19-9 should be routinely measured in the colorectal patients with preoperative normal serum CEA: a multicenter retrospective cohort study

  2022cites this paper
• Comparison of Proportion of Elevated Carcinoembryonic Antigen Levels in Patients With Appendiceal and Colorectal Adenocarcinoma: A Systematic Review and Meta-analysis

  2022cites this paper
• Comment on “Risk factors for metachronous peritonealcarcinomatosis after radical resection for patients with nonmetastatic pT3‐4 colon cancer”

  2022cites this paper
• Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study

  2021cites this paper
• Novel Prognostic Role of Serum CA19-9 Identified in Colorectal Terminal Tumor Site and Tubular Adenocarcinoma

  2020cites this paper
• Metastatic Colorectal Cancer: Prognostic And Predictive Factors.

  2020cites this paper
• Tumor slice culture as a biologic surrogate of human cancer.

  2020influential citation
• Differential diagnosis of liver metastases of gastrointestinal stromal tumors from colorectal cancer based on combined tumor biomarker with features of conventional ultrasound and contrast-enhanced ultrasound

  2020cites this paper
• Clinical significance and diagnostic value of serum NSE, CEA, CA19-9, CA125 and CA242 levels in colorectal cancer

  2020cites this paper
• Prognostic Value of Pretreatment Serum CA199 in Patients with Locally Advanced Rectal Cancer Treated with CRT Followed by TME with Normal Pretreatment Carcinoembryonic Antigen Levels

  2020cites this paper
• Preoperative CA125 value predicts Glisson capsule involvement in patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

  2019cites this paper
• Offsetting Expression Profiles of Prognostic Markers in Prostate Tumor vs. Its Microenvironment

  2019cites this paper
• Relevance of baseline carcinoembryonic antigen for first-line treatment against metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial).

  2019cites this paper
• Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer

  2018cites this paper
• CEA to peritoneal carcinomatosis index (PCI) ratio is prognostic in patients with colorectal cancer peritoneal carcinomatosis undergoing cytoreduction surgery and intraperitoneal chemotherapy

  2018cites this paper
• Biomarkers for the early detection of relapses in metastatic colorectal cancers.

  2017cites this paper
• Baseline carcinoembryonic antigen as a predictive factor of ramucirumab efficacy in RAISE, a second-line metastatic colorectal carcinoma phase III trial.

  2017cites this paper
• Baseline and On-Treatment Markers Determining Prognosis of First-Line Chemotherapy in Combination with Bevacizumab in Patients with Metastatic Colorectal Cancer

  2017cites this paper
• Methylated free‐circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancer

  2017cites this paper
• Evaluation of some tumor markers, acute phase proteins, sialic acid and lipid bound sialic acid before and after chemotherapy in patients with stomach cancer

  2016cites this paper
• Relevance of CEA and LDH in relation to KRAS status in patients with unresectable colorectal liver metastases

  2016cites this paper
• Prognostic Value of Carcinoembryonic Antigen (CEA), AFP, CA19-9 and CA125 for Patients with Colorectal Cancer with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy.

  2016cites this paper
• Use of Tumor Markers in Gastrointestinal Cancers: Surgeon Perceptions and Cost-Benefit Trade-Off Analysis

  2016cites this paper
• Identifying Appropriate Colorectal Cancer-Associated Antigens for the Clinical Trials

  2015cites this paper
• The Role of Human Chorionic Gonadotropin as Tumor Marker: Biochemical and Clinical Aspects.

  2015cites this paper
• Arginase-1 is a more sensitive marker than HepPar-1 and AFP in differential diagnosis of hepatocellular carcinoma from nonhepatocellular carcinoma

  2015cites this paper
• Elevated CA19-9 as the Most Significant Prognostic Factor in Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy

  2015cites this paper
• Preoperative serum markers for individual patient prognosis in stage I–III colon cancer

  2015cites this paper
• Imaging biomarkers of the tumour microenvironment to assess early response in patients treated with anti-angiogenic therapy

  2015cites this paper
• Beta-Human Chorionic Gonadotropin Expression in Recurrent and Metastatic Giant Cell Tumors of Bone

  2014cites this paper
• Clinico-Pathological Patterns and Survival outcome of Colorectal Cancer in Young Saudi Arabian Patients

  2014influential citation
• Prognostic factors for metastatic colorectal cancer after first-line chemotherapy with FOLFOX-4 or FOLFIRI regimen.

  2014cites this paper
• Clinico-pathological patterns and survival outcome of colorectal cancer in young patients: western Saudi Arabia experience.

  2014cites this paper
• Evaluation of preoperative serum markers for individual patient prognosis in stage I–III rectal cancer

  2014cites this paper
• Baseline carcinoembryonic antigen (CEA) serum levels predict bevacizumab-based treatment response in metastatic colorectal cancer

  2014cites this paper
• Verification of multimarkers for detection of early stage diabetic retinopathy using multiple reaction monitoring.

  2013cites this paper
• Patient Selection for Cytoreductive Surgery in Colorectal Peritoneal Carcinomatosis Using Serum Tumor Markers: An Observational Cohort Study

  2012cites this paper
• Regional liver therapy using oncolytic virus to target hepatic colorectal metastases.

  2010cites this paper
• The study of p53 and CA19-9 prognostic molecular markers in colorectal carcinomas.

  2010cites this paper
• Colorectal Carcinoma with Extremely Low CA19-9

  2009cites this paper
• A herpes oncolytic virus can be delivered via the vasculature to produce biologic changes in human colorectal cancer.

  2009cites this paper
• Impact of baseline sum of longest diameter in target lesions by RECIST on survival of patients with metastatic colorectal cancer.

  2008cites this paper
• Prognosis in non-metastatic colorectal cancer: multivariate evaluation of preoperative levels of six tumor markers in addition to clinical parameters / Multivariate Analyse der prognostischen Aussagekraft von sechs präoperativen Tumormarkern zusätzlich zu klinischen Parametern beim nicht metastasier

  2007cites this paper
• Ectopic hCGbeta expression by epithelial cancer: malignant behaviour, metastasis and inhibition of tumor cell apoptosis.

  2007cites this paper
• Human chorionic gonadotrophin beta expression in malignant Barrett’s oesophagus

  2004influential citation
• Human chorionic gonadotropin in cancer.

  2004cites this paper
• Prognostic significance of the p185 protein in colorectal cancer.

  2004cites this paper
• Predictive factors for response to chemotherapy in colorectal cancer patients.

  2004cites this paper
• Prognostic significance of thymidylate synthase in patients with metastatic colorectal cancer who receive protracted venous infusions of 5-fluorouracil

  2004cites this paper
• Natural killer (NK) cell function is a strong prognostic factor in colorectal carcinoma patients treated with the monoclonal antibody 17‐1A

  2003cites this paper
• Endoscopic follow-up of patients after curative surgery for colorectal cancer: results of a medical assistance protocol.

  2003cites this paper
• Clinical and molecular prognostic factors in patients with metastatic colorectal cancer treated with 5-fluorouracil-based chemotherapy.

  2003cites this paper
• Ectopic human chorionic gonadotropin beta secretion by epithelial tumors and human chorionic gonadotropin beta-induced apoptosis in Kaposi's sarcoma: is there a connection?

  2003cites this paper
• Monoclonal antibodies to two epitopes of beta-human chorionic gonadotropin for the treatment of cancer.

  2003cites this paper
• Prediction of distant metastases after curative surgery for rectal cancer.

  2002cites this paper
• CA19-9 as the most significant prognostic indicator of metastatic colorectal cancer.

  2002cites this paper
• Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients.

  2002influential citation
• Klinische Prognosefaktoren für das kolorektale Karzinom

  2002cites this paper
• Expression of the free beta subunit of human chorionic gonadotropin in cancer of the urinary bladder and kidney

  2002cites this paper
• Combination of HCGbeta, CA 19-9 and CEA with logistic regression improves accuracy in gastrointestinal malignancies.

  2002cites this paper
• Prognostic Factors for Patients With Metastatic Colorectal Cancer Receiving Protracted Venous Infusion of 5-FU

  2002cites this paper
• Serum HCGβ, CA 72‐4 and CEA are independent prognostic factors in colorectal cancer

  2002cites this paper
• [Standards, options and recommendations for tumor markers in colorectal cancer].

  2002cites this paper
• Active specific immunotherapy with a beta-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: antibody response is associated with improved survival.

  2002cites this paper
• Preoperative serum levels of sialyl Lewis(a), sialyl Lewis(x), and sialyl Tn antigens as prognostic markers after curative resection for colorectal cancer.

  2001cites this paper
• The HER-2/neu Oncogene in Tumors of the Gastrointestinal Tract

  2001cites this paper
• Specific staining of human chorionic gonadotropin β in benign and malignant gastrointestinal tissues with monoclonal antibodies

  2001cites this paper
• Circulating sialyl Lewisx, sialyl Lewisa, and sialyl Tn antigens in colorectal cancer patients: multivariate analysis of predictive factors for serum antigen levels

  2001cites this paper
• Tissue expression of human chorionic gonadotropin β predicts outcome in colorectal cancer: A comparison with serum expression

  2001cites this paper
• Prognostic value of circulating sialyl Tn antigen in colorectal cancer patients.

  2000cites this paper
• CA 125: a clinically useful tumor marker in the management of colorectal carcinoma metastatic to the liver in patients with normal carcinoembryonic antigen.

  2000cites this paper
• Is there any correlation between MDR1, GST-pi-expression and CEA?

  2000cites this paper
• A clinical nomogram for predicting long-term survival in advanced colorectal cancer.

  2000cites this paper
• A comparison of serum and tissue hCG beta as prognostic markers in colorectal cancer.

  2000cites this paper
• Clinicopathological significance of erbB-2 expression in colorectal carcinoma.

  1999cites this paper
• Influence of metastatic site as an additional predictor for response and outcome in advanced colorectal carcinoma

  1999cites this paper
• Increased mortality in postmenopausal women with serum CA125 elevation.

  1999cites this paper
• Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG. European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group.

  1998cites this paper
• [Which techniques are useful for diagnosis of colonic cancer and for therapeutic choice?].

  1998cites this paper
• Evaluation of Clinical Efficacy of New Medical Treatments in Advanced Colorectal Cancer. Results of a Workshop Organized by the Eortc Gitccg

  1998cites this paper
• The utility of monitoring carcinoembyronic antigen during systemic therapy for advanced colorectal cancer.

  1998cites this paper
• Leukocyte Alkaline Phosphatase, CA15-3, CA125, and CEA in Cancer Patients

  1998cites this paper
• The prognostic significance of beta human chorionic gonadotrophin and its metabolites in women with cervical carcinoma.

  1998cites this paper
• Immunohistochemical localization of epithelial glycoprotein EGP-2 and carcinoembryonic antigen in normal colonic mucosa and colorectal tumors.

  1998cites this paper
• Bcl-2 expression and response to chemotherapy in colorectal adenocarcinomas.

  1997cites this paper
• Molecular biology of colorectal cancer.

  1997cites this paper
• Prognostic implications of c-Ki-ras2 mutations in patients with advanced colorectal cancer treated with 5-fluorouracil and interferon: a study of the eastern cooperative oncology group (EST 2292)

  1997cites this paper
• Clinical prognostic factors of colorectal carcinomas

  year unknowncites this paper